NCT04675645View on ClinicalTrials.gov

Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

July 11, 2020

Study Completion Date

July 11, 2020

Conditions
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero ThalassemiaSickle Cell Hemoglobin C
Interventions
OTHER

HU-Go app

A novel multifunctional mobile app (HU-Go) to improve adherence to hydroxyurea in patients with sickle cell disease

Trial Locations (1)

60611

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT04675645 - Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App | Biotech Hunter | Biotech Hunter